Life Flow

Life Flow is a MedTech startup focused on cardiac diagnostics, leading the way with advanced Computational Fluid Dynamics technology. The company has developed a technology allowing non-invasive assessment of the functional significance of coronary artery lesions, utilizing Computational Fluid Dynamics (CFD) methods. With 2.5 million people diagnosed with coronary heart disease (CHD) in Europe annually, and CHD responsible for one in every five deaths in developed countries, there is a significant market for non-invasive cardiac diagnostics. Currently, coronary angiography is the typical diagnostic method, which is costly, invasive, and carries risks for patients. LifeFlow addresses this with its iSIL-FFR, a post-processing software delivered as Software as a Service (SaaS) in the cloud, offering non-invasive assessment of coronary artery lesions through a three-dimensional reconstruction of the arteries and numerical simulations of blood flow. Founded in 2015, LifeFlow received its last investment as a Seed Round from LSI (Life Science Innovations Fund) on November 17, 2015. The estimated annual market potential for LifeFlow's diagnostic services is 1 million in Europe and 1.25 million in the US. The company operates in the Health Care, Life Sciences, and SaaS industries.